中国中免2025年三季度净利润同比下降28.94%

Core Insights - China National Pharmaceutical Group (China National Immunization) reported a revenue of 11.711 billion yuan for Q3 2025, reflecting a year-on-year decline of 0.38% [1] - The net profit attributable to shareholders of the listed company was 452 million yuan, down 28.94% year-on-year [1] Financial Performance - Revenue: 11.711 billion yuan, down 0.38% year-on-year [1] - Net Profit: 452 million yuan, down 28.94% year-on-year [1]